The influence of diabetes on in-hospital and long-term mortality in patients with myocardial infarction complicated by cardiogenic shock: Results from the PL-ACS registry

Kardiologia Polska

Volumn 70, Issue 12, 2012, Pages 1215-1224

  Ga̧sior, Mariusz ^a   Pres, Damian ^a   Gierlotka, Marek ^a   Hawranek, Michał ^a   Słonka, Grzegorz ^a   Lekston, Andrzej ^a   Buszman, Paweł ^a   Kalarus, Zbigniew ^a   Zembala, Marian ^a   Polonśki, Lech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cardiogenic shock; Diabetes mellitus; Myocardial infarction

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; CONSERVATIVE TREATMENT; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBESITY; PROGNOSIS; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 84872085080     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lekston A, Slonka G, Gasior M et al. Comparison of early and long-term results of percutaneous coronary interventions in patients with ST elevation myocardial infarction, complicated or not by cardiogenic shock. Coron Artery Dis, 2010; 21: 13-19.
2. Lindholm MG, Køber L, Boesgaard S et al. Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development. Eur Heart J, 2003; 24: 258-265.
3. Singh M, White J, Hasdai D et al. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial. J Am Coll Cardiol, 2007; 50: 1752-1758.
4. Hochman JS, Sleeper LA, Webb JG et al.; SHOCK Investigators. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA, 2006; 295: 2511-2515.
5. Franklin K, Goldberg RJ, Spencer F et al.; GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med, 2004; 164: 1457-1463.
6. McGuire DK, Emanuelsson H, Granger CB et al. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators. Eur Heart J, 2000; 21: 1750-1758.
7. Donahoe SM, Stewart GC, McCabe CH et al. Diabetes and mortality following acute coronary syndromes. JAMA, 2007; 298: 765-775.
8. Hasdai D, Califf RM, Thompson TD et al. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol, 2000; 35: 136-143.
9. Hasin T, Hochadel M, Gitt AK et al. Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus. Am J Cardiol, 2009; 103: 772-778.
10. Shindler DM, Palmeri ST, Antonelli TA et al. Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol, 2000; 36: 1097-1103.
11. Lindholm MG, Boesgaard S, Torp-Pedersen C et al. Diabetes mellitus and cardiogenic shock in acute myocardial infarction. Eur J Heart Fail, 2005; 7: 834-839.
12. Tedesco JV, Wright RS, Williams BA et al. Effect of diabetes on the mortality risk of cardiogenic shock in a community-based population. Mayo Clin Proc, 2003; 78: 561-566.
13. Farkouh ME, Ramanathan K, Aymong ED et al. An early revascularization strategy is associated with a survival benefit for diabetic patients in cardiogenic shock after acute myocardial infarction. Clin Cardiol, 2006; 29: 204-210.
14. Polonski L, Gasior M, Gierlotka M et al. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol Pol, 2007; 65: 861-872.
15. Flynn MR, Barrett C, Cosío FG et al. The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice. Eur Heart J, 2005; 26: 308-313.
16. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J, 2000; 21: 1502-1513.
17. Granger CB, Califf RM, Young S et al. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol, 1993; 21: 920-925.
18. Harjai KJ, Stone GW, Boura J et al. Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction. Am J Cardiol, 2003; 91: 1041-1045.
19. White HD, Assmann SF, Sanborn TA et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation, 2005; 112: 1992-2001.
20. Giri S, Mitchel J, Azar RR et al. Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol, 2002; 89: 126-131.
21. Antman EM, Anbe DT, Armstrong PW et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology//American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol, 2004;44: E1-E211.
22. Antman EM, Hand M, Armstrong PW et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation, 2008; 117: 296-329.
23. Wijns W, Kolh P, Danchin N et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 2010; 31: 2501-2555.
24. Bassand JP, Hamm CW, Ardissino D et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J, 2007; 28: 1598-1660.
25. Anderson JL, Adams CD, Antman EM et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation, 2007; 116: 148-304.
26. Hamm CW, Bassand JP, Agewall S et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J, 2011; 32: 2999-3054.
27. Carnendran L, Abboud R, Sleeper LA et al. Trends in cardiogenic shock: report from the SHOCK Study. The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? Eur Heart J, 2001; 22: 472-478.
28. Hochman JS, Sleeper LA, Webb JG et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med, 1999; 341: 625-34.
29. Hochman JS, Sleeper LA, White HD et al. One-year survival following early revascularization for cardiogenic shock. JAMA, 2001; 285: 190-192.
30. Gasior M, Slonka G, Wilczek K et al. Comparison of invasive and non-invasive treatment strategies in older patients with acute myocardial infarction complicated by cardiogenic shock (from the Polish Registry of Acute Coronary Syndromes: PL-ACS). Am J Cardiol, 2011; 107: 30-36.